TrialThe Lancet. Haematology2026

Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study.

Tanja A Gruber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.